Bringing the fundamentals into focus…
Back to Vericel Corporation
How Vericel Corporation stacks up
VCEL · against 403 other Healthcare companies of similar size
Valuation
41/ 100
Below the middle of the pack.
Ranked #246 of 404 · scores higher than 39% of peers
Bars: peers in each 10-point band of the valuation score42 peers with a valuation score of 40–49, including VCEL · Click a bar to see the companies
Why valuation scores 41?
Weighted metrics compared with all Healthcare companies.A mix: stronger free cash flow yield, but weaker EBITDA yield than most Healthcare peers.
- less operating profit (EBITDA) for the company's total value: weaker than 63% of peers. EBITDA yield: 1.5% vs peer median 4.0%
- Earnings yield is close to the peer norm. Earnings yield: 1.2% vs peer median 1.5%
- more free cash flow for the price paid: stronger than 67% of peers. Free cash flow yield: 2.9% vs peer median 0.0%
Metric by metric
Position: dot = VCEL, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | VCEL | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 392 reported | 1.2% | 1.7% | 47% | 30% | |
| EBITDA yieldHigher is better · 404 reported | 1.5% | 4.3% | 35% | 50% | |
| Free cash flow yieldHigher is better · 198 reported | 2.9% | -0.5% | 66% | 20% | |
| Book yieldHigher is better · 395 reported | 17.6% | 34.6% | 24% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around VCELScores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score